Order Article Reprints

Gabizon A, Shmeeda H, Draper B, Parente-Pereira A, Maher J, Carrascal-Miniño A, de Rosales RTM, La-Beck NM. Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes. Pharmaceutics. 2023; 15(11):2606. https://doi.org/10.3390/pharmaceutics15112606

Gabizon, Alberto, Hilary Shmeeda, Benjamin Draper, Ana Parente-Pereira, John Maher, Amaia Carrascal-Miniño, Rafael T. M. de Rosales, and Ninh M. La-Beck. 2023. "Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes" Pharmaceutics 15, no. 11: 2606. https://doi.org/10.3390/pharmaceutics15112606

Gabizon, A., Shmeeda, H., Draper, B., Parente-Pereira, A., Maher, J., Carrascal-Miniño, A., de Rosales, R. T. M., & La-Beck, N. M. (2023). Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes. Pharmaceutics, 15(11), 2606. https://doi.org/10.3390/pharmaceutics15112606